<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.46624/ajptr.2020.v10.i3.008</article-id>
      <article-id pub-id-type="publisher-id">AJPTR103008</article-id>
      <title-group>
        <article-title>A Review on Stability Development Guidelines and Impurities Profile Consideration in Solid Oral Dosage Form</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kadlag</surname>
            <given-names>Dnyaneshwar Bharat</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Navale</surname>
            <given-names>Santosh Dattu</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patil</surname>
            <given-names>S. B.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Upasani</surname>
            <given-names>C. D.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2020-06-01">
        <month>06</month>
        <day>01</day>
        <year>2020</year>
      </pub-date>
      <volume>10</volume>
      <issue>3</issue>
      <abstract>
        <p>In the pharmaceutical industry an impurity is considered, defined the any other organic material besides the drug substance or pharmaceutical ingredients.  The impurity may be formed during the formulation or upon aging of two APIs in medicines. Stability testing is an integral part of pharmaceutical development. The primary purpose of stability testing is to provide supporting evidence on stability behavior of pharmaceutical drug products. Stability is the capacity of a drug product to remain within specifications established to ensure its identity, strength, quality and purity.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Impurity</kwd>
        <kwd>Stability</kwd>
        <kwd>ICH</kwd>
        <kwd>Annexure.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
